Blum Holdings (Blum Holdings) 3-Year EBITDA Growth Rate : -5.00% (As of Sep. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Blum Holdings 3-Year EBITDA Growth Rate?

Blum Holdings's EBITDA per Share for the three months ended in Sep. 2023 was $-0.11.

During the past 3 years, the average EBITDA Per Share Growth Rate was -5.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 26.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 25.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Blum Holdings was 74.70% per year. The lowest was -1779.80% per year. And the median was 8.20% per year.

Competitive Comparison of Blum Holdings's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Blum Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Blum Holdings's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blum Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Blum Holdings's 3-Year EBITDA Growth Rate falls into.

Blum Holdings 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Blum Holdings (OTCPK:BLMH) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Blum Holdings 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Blum Holdings's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Blum Holdings (Blum Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blum Holdings Inc (OTCPK:BLMH) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

3242 South Halladay Street, Suite 202, Santa Ana, CA, USA, 92705

Website

https://www.unrivaledbrands.com

Blum Holdings Inc formerly Unrivaled Brands Inc is a vertically integrated cannabis multi-state operator having a cannabis brand spanning consumer products, cultivation, distribution, and retail. Its brands include Korova, Sticks, and Cabana, among others. It operates leading dispensaries throughout the state as well as several leading company-owned brands including Korova, known for its high potency products across multiple product categories.

Executives

Patty Chan	officer: CHIEF FINANCIAL OFFICER	11516 DOWNEY AVE, DOWNEY CA 90241
Oren Schauble	officer: President	3242 S HALLADAY ST., SUITE 202, SANTA ANA CA 92705
Dallas Imbimbo	director	1800 NEWPORT CIRCLE, SANTA ANA CA 92705
Eric Baum	director	866 BERKSHIRE DRIVE, WESTBURY NY 11590
Tiffany N. Davis	director	11852 MANHATTAN CT., RANCHO CUCAMONGA CA 91730
Michael Nahass	director	2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Derek Peterson	director, officer: President and CEO	2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Alan David Gladstone	other: Former Director of Issuer	P.O BOX 9699, NEWPORT BEACH CA 92658
Uri Kenig	officer: Chief Operating Officer	2040 MAIN ST., SUITE 225, IRVINE CA 92614
Ira E. Ritter	director	C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
Nicholas Kovacevich	director	2618 SAN MIGUEL DRIVE, #480, NEWPORT BEACH CA 92660
Knuettel Ii Francis	director	205 NEWBURY ST, SUITE 204, FRAMINGHAM MA 01701
Jeffrey Robert Batliner	officer: Chief Financial Officer	2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Megan Jimenez	officer: Chief Financial Officer	2040 MAIN ST., SUITE 225, IRVINE CA 92614
Matthew Morgan	director, officer: Chief Executive Officer	2040 MAIN STREET, SUITE 225, IRVINE CA 92614